1h Free Analyst Time
The publisher has been monitoring the carrier screening market and it is poised to grow by $2.36 bn during 2022-2026, progressing at a CAGR of 17.66% during the forecast period. The report on the carrier screening market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of genetic diseases and disorders, the increasing prevalence of fetal chromosomal abnormalities, and rising consciousness among the masses regarding the benefits of early detection and diagnosis of diseases.
The carrier screening market analysis includes the type segment and geographic landscape.
The carrier screening market is segmented as below:
By Type
- Expanded carrier screening
- Targeted disease carrier screening
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the rising trends of next-generation sequencing (NGS) technology in carrier screening as one of the prime reasons driving the carrier screening market growth during the next few years. Also, extensive R&D activities in the field of biotechnology and bioinformatics and significant growth in the medical infrastructure will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on carrier screening market covers the following areas:
- Carrier screening market sizing
- Carrier screening market forecast
- Carrier screening market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading carrier screening market vendors that include Abbott Laboratories, Agilent Technologies Inc., CENTOGENE NV, Danaher Corp., Eurofins Scientific SE, DiaSorin SpA, F. Hoffmann La Roche Ltd., Fulgent Genetics, Gene By Gene Ltd, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 OpCo Inc., and Thermo Fisher Scientific Inc. Also, the carrier screening market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher announces the Publication of its Research Report - Global Carrier Screening Market 2022-2026The publisher recognizes the following companies as the key players in the global carrier screening market: Abbott Laboratories, Agilent Technologies Inc., CENTOGENE NV, Danaher Corp., Eurofins Scientific SE, DiaSorin SpA, F. Hoffmann La Roche Ltd., Fulgent Genetics, Gene By Gene Ltd, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 OpCo Inc., and Thermo Fisher Scientific Inc.
Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is rising trends of next-generation sequencing (NGS) technology in carrier screening.'
According to the report, one of the major drivers for this market is the rising prevalence of genetic diseases and disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies Inc.
- CENTOGENE NV
- Danaher Corp.
- Eurofins Scientific SE
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- Fulgent Genetics
- Gene By Gene Ltd
- Illumina Inc.
- Invitae Corp.
- Laboratory Corp. of America Holdings
- MedGenome Labs Ltd.
- Myriad Genetics Inc.
- Natera Inc.
- OPKO Health Inc.
- Otogenetics Corporation
- Quest Diagnostics Inc.
- Sema4 OpCo Inc.
- Thermo Fisher Scientific Inc.
